156 related articles for article (PubMed ID: 28835099)
21. PEG prodrugs of 6-mercaptopurine for parenteral administration using benzyl elimination of thiols.
Choe YH; Greenwald RB; Conover CD; Zhao H; Longley CB; Guan S; Zhao Q; Xia J
Oncol Res; 2004; 14(9):455-68. PubMed ID: 15490977
[TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
Auzenne E; Ghosh SC; Khodadadian M; Rivera B; Farquhar D; Price RE; Ravoori M; Kundra V; Freedman RS; Klostergaard J
Neoplasia; 2007 Jun; 9(6):479-86. PubMed ID: 17603630
[TBL] [Abstract][Full Text] [Related]
23. Glutathione-dependent metabolism of cis-3-(9H-purin-6-ylthio)acrylic acid to yield the chemotherapeutic drug 6-mercaptopurine: evidence for two distinct mechanisms in rats.
Gunnarsdottir S; Elfarra AA
J Pharmacol Exp Ther; 1999 Sep; 290(3):950-7. PubMed ID: 10454464
[TBL] [Abstract][Full Text] [Related]
24. Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles.
Zhong Y; Meng F; Deng C; Mao X; Zhong Z
Drug Deliv; 2017 Nov; 24(1):1482-1490. PubMed ID: 28958164
[TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid-based prodrug nanomedicines for enhanced tumor targeting and therapy: A review.
Zhang R; Zhao X; Jia A; Wang C; Jiang H
Int J Biol Macromol; 2023 Sep; 249():125993. PubMed ID: 37506794
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina.
Huang D; Chen YS; Rupenthal ID
Mol Pharm; 2017 Feb; 14(2):533-545. PubMed ID: 27997199
[TBL] [Abstract][Full Text] [Related]
27. Effect of aminomethyl (N-Mannich base) derivatization on the ability of S6-acetyloxymethyl-6-mercaptopurine prodrug to deliver 6-mercaptopurine through hairless mouse skin.
Saab AN; Sloan KB; Beall HD; Villaneuva R
J Pharm Sci; 1990 Dec; 79(12):1099-104. PubMed ID: 2079657
[TBL] [Abstract][Full Text] [Related]
28. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
[TBL] [Abstract][Full Text] [Related]
29. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
[TBL] [Abstract][Full Text] [Related]
30. PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
Choi KY; Min KH; Yoon HY; Kim K; Park JH; Kwon IC; Choi K; Jeong SY
Biomaterials; 2011 Mar; 32(7):1880-9. PubMed ID: 21159377
[TBL] [Abstract][Full Text] [Related]
31. CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage.
Hu JB; Li SJ; Kang XQ; Qi J; Wu JH; Wang XJ; Xu XL; Ying XY; Jiang SP; You J; Du YZ
Carbohydr Polym; 2018 Aug; 193():268-280. PubMed ID: 29773381
[TBL] [Abstract][Full Text] [Related]
32. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
[TBL] [Abstract][Full Text] [Related]
33. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal Macrophage-Specific TNF-α Gene Silencing in LPS-Induced Acute Inflammation Model Using CD44 Targeting Hyaluronic Acid Nanoparticles.
Kosovrasti VY; Nechev LV; Amiji MM
Mol Pharm; 2016 Oct; 13(10):3404-3416. PubMed ID: 27552547
[TBL] [Abstract][Full Text] [Related]
35. Preparation, characterization, and in vitro drug release behavior of glutathione-sensitive long-circulation micelles based on polyethylene glycol prodrug.
Shi L; Ding K; Sun X; Zhang L; Zeng T; Yin Y; Zheng H
J Biomater Sci Polym Ed; 2016; 27(6):472-89. PubMed ID: 26764973
[TBL] [Abstract][Full Text] [Related]
36. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor.
Du F; Lou J; Jiang R; Fang Z; Zhao X; Niu Y; Zou S; Zhang M; Gong A; Wu C
Int J Nanomedicine; 2017; 12():5973-5992. PubMed ID: 28860761
[TBL] [Abstract][Full Text] [Related]
38. Renal cellular transport, metabolism, and cytotoxicity of S-(6-purinyl)glutathione, a prodrug of 6-mercaptopurine, and analogues.
Lash LH; Shivnani A; Mai J; Chinnaiyan P; Krause RJ; Elfarra AA
Biochem Pharmacol; 1997 Dec; 54(12):1341-9. PubMed ID: 9393677
[TBL] [Abstract][Full Text] [Related]
39. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronic acid-coated liposomes for active targeting of gemcitabine.
Arpicco S; Lerda C; Dalla Pozza E; Costanzo C; Tsapis N; Stella B; Donadelli M; Dando I; Fattal E; Cattel L; Palmieri M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):373-80. PubMed ID: 23791684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
